相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial
F. Ciardiello et al.
ANNALS OF ONCOLOGY (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Clinical relevance of KRAS mutations in codon 13: Where are we?
Tze-Kiong Er et al.
CANCER LETTERS (2014)
The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism
Victor Jeannot et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
Yu Imamura et al.
MOLECULAR CANCER (2014)
KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
Aristea Kalikaki et al.
PLOS ONE (2014)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells
Hiu-Fung Yuen et al.
BIOSCIENCE REPORTS (2012)
Calpains mediate epithelial-cell death during mammary gland involution: mitochondria and lysosomal destabilization
T. Arnandis et al.
CELL DEATH AND DIFFERENTIATION (2012)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival
D. J. Hartman et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Mouse Tissues that Undergo Neoplastic Progression after K-Ras Activation Are Distinguished by Nuclear Translocation of phospho-Erk1/2 and Robust Tumor Suppressor Responses
Neha Parikh et al.
MOLECULAR CANCER RESEARCH (2012)
Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17
Sandra Van Schaeybroeck et al.
CANCER RESEARCH (2011)
The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
Melissa J. LaBonte et al.
CANCER RESEARCH (2011)
HSV-1 Cgal+ Infection Promotes Quaking RNA Binding Protein Production and Induces Nuclear-Cytoplasmic Shuttling of Quaking I-5 Isoform in Human Hepatoma Cells
Virginia Sanchez-Quiles et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells
Lin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Functional diversity of the hnRNPs: past, present and perspectives
Siew Ping Han et al.
BIOCHEMICAL JOURNAL (2010)
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine
G. Smith et al.
BRITISH JOURNAL OF CANCER (2010)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells
Elisabeth Emonds et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
Jeffrey W. Tyner et al.
BLOOD (2009)
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F. Loupakis et al.
BRITISH JOURNAL OF CANCER (2009)
Heterogeneous Nuclear Ribonucleoprotein A1 Is Identified as a Potential Biomarker for Colorectal Cancer Based on Differential Proteomics Technology
Yan-Lei Ma et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells
L-C Chen et al.
ONCOGENE (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling
Hideko Hayashi et al.
GENES TO CELLS (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
hnRNP A1 relocalization to the stress granules reflects a role in the stress response
Sonia Guil et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Weaning induces NOS-2 expression through NF-κB modulation in the lactating mammary gland:: importance of GSH
R Zaragozá et al.
BIOCHEMICAL JOURNAL (2005)
Ras/MAP Kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate
JW Jung et al.
CANCER LETTERS (2005)
Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts
N Dourdin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
